Tissue Agnostic Drug Development in Oncology: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
October 17, 2022
February 5, 2025
3835823e-c995-46e5-98c7-9422ad94971f
Related Documents
Drug Master Files Guidance for Industry
Guidance DocumentNovember 15, 2019Center for Drug Evaluation and Research
QTc Information in Human Prescription Drug and Biological Product Labeling: Draft Guidance for Industry
Guidance DocumentAugust 8, 2023Office of the Commissioner
Considerations for Rescinding Breakthrough Therapy Designation
Guidance DocumentJune 24, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox